Text module with clinical insights from Joyce O Shaughnessy, MD, on some of the most important developments in the management of HR-positive/HER2-negative breast cancer, including how to apply the latest clinical trial results and their implications for high-risk disease.
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/oncology/hr-positive-her2-negative-bc/18611-27545
- Start Date: 2024-03-22 05:00:00
- End Date: 2024-03-22 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Lilly (Any division) - Amount: 0.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest